Study documents comfort, safety of silicone hydrogel daily disposable compared with spectacle wear

Article

Results from a study seem to dispel the myth that comfort and physiology may affect patients who are initiating contact lens wear.

San Francisco-Results from a prospective, randomized study seem to dispel the myth that comfort and physiology may affect patients who are initiating contact lens (CL) wear, said Jeffrey J. Walline, OD, PhD, here at the American Academy of Optometry's annual meeting.

Early findings

After 1 week of CL wear, results showed that spectacles were slightly more comfortable late in the day. However, after 1 month of wear, comfort was comparable between the two groups, which suggests that there may be a slight adaptation when adjusting to CL wear, said Dr. Walline, assistant professor, Ohio State University College of Optometry, Columbus.

Analysis of the collected physiology data noted statistical equivalence at a 99% confidence level for corneal vascularization, conjunctival hyperemia, limbal hyperemia and corneal staining at the 6-month visit. Conjunctival staining and papillary conjunctivitis were greater in the CL wearers at the 6-month interval.

"Most studies investigating new CLs will include patients wearing another CL as the comparator group. Our study design using spectacle wearers as the control is unique and allows us to address the assumptions that CLs are not as comfortable as spectacle wear and may compromise the ocular surface," said Dr. Walline.

"The findings from our study show that even in patients with no history of [CL] wear, this new [SiH DD CL], which combines oxygen transmissibility with the convenience of single use, is associated with similar comfort and ocular physiology compared with spectacle wear."

Dr. Walline noted that while the results of this study cannot be directly generalized to other CL products, the performance of other SiH DD CLs may be similar.

"Such studies have yet to be conducted," he said.

Recent Videos
Cecilia Koetting, OD, FAAO, DipABO, cited data from a recent student that found that presbyopia treatment with 0.4% pilocarpine led to up to 86% of patients achieving 20/40 or better.
Kerry Giedd, OD, MS, FAAO, was 1 of 20 investigators around the country for a study evaluating the daily disposable contact lens.
According to A. Paul Chous, MA, OD, FAAO, optometrists have an important opportunity to educate patients in their chairs about diabetes.
David Geffen, OD, FAAO, gave a poster presentation titled "Revolutionizing Comfort: Unveiling the Potential of Perfluorohexyloctane Eyedrops for Contact Lens Wearers" at this year's Academy meeting.
Jessica Steen, OD, FAAO, Dipl-ABO, discussed ophthalmic considerations for patients undergoing treatment with antibody drug conjugates for gynecologic cancers at this year's conference.
A. Paul Chous, MA, OD, FAAO, details a presentation on this year's updates on diabetes given at this year's Academy meeting
Sherrol Reynolds, OD, FAAO, said that multimodel imaging has been a game changer in assessing the choroidal function and structural changes in various disease conditions.
Susan Gromacki, OD, FAAO, FSLS, provides key takeaways from this year's American Academy of Optometry symposium genetics and the cornea.
Roya Attar gives an overview of her presentation, "Decoding the Retina: The Value of Genetic Testing In Inherited Disorders," presented with Mohammad Rafieetary, OD, FAAO, FORS, ABO, ABCMO.
Ian Ben Gaddie, OD, FAAO, outlines key findings from a recent study evaluating lotilaner in patients with Demodex blepharitis and meibomian gland dysfunction.
© 2024 MJH Life Sciences

All rights reserved.